Fulgent Genetics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fulgent Genetics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $10.9M, a 0.17% increase year-over-year.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $45.5M, a 9.62% increase year-over-year.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $42.9M, a 31.5% increase from 2022.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32.6M, a 106% increase from 2021.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.9M, a 94.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $42.9M +$10.3M +31.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $32.6M +$16.8M +106% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $15.9M +$7.73M +94.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $8.16M +$4.95M +154% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.21M +$905K +39.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $2.3M +$185K +8.73% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $2.12M -$2.54M -54.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $4.65M -$3.5M -42.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
2015 $8.16M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.